| Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2 (NCT04846010) | All Natural Medicine Clinic, LLC | 2021-03-01 |
| IM Ketamine vs Midazolam for Suicidal ER Patients (NCT04640636) | New York State Psychiatric Institute | 2021-02-09 |
| Music as an Intervention to Improve Hemodynamic Tolerability of Ketamine in Depression (NCT04701866) | Douglas Mental Health University Institute | 2021-01-11 |
| LIVES: Personalized Lifestyle Intervention for Patients With Depression (NCT05767073) | University Medical Center Groningen | 2020-09-01 |
| The Effect of S-ketamine for Patients Undergoing Electroconvulsive Therapy (ECT) (NCT04399070) | Yan Qiu | 2020-08-01 |
| Optimal Electrical Stimulus During Electroconvulsive Therapy (NCT04057378) | Region Örebro County | 2019-10-30 |
| Pramipexole to Target "Anhedonic Depression" (NCT04121091) | Region Skane | 2019-10-04 |
| Management of my Bipolarity Intervention in Bipolar Disorder Patients (NCT04643210) | Cyprus University of Technology | 2018-07-30 |
| Chronobiology and Depression: Circadian Analytics as a Biomarker for Depressive Subtypes (NCT03538275) | Medibio Limited | 2018-03-13 |
| A Study of Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar Depression (NCT03423680) | Korea Otsuka Pharmaceutical Co., Ltd. | 2018-02-22 |
| The Effects of tDCS on Depressive Symptoms,Neurocognitive Function and HRV in Unipolar Depression and Bipolar Depression (NCT03287037) | Tri-Service General Hospital (TSGH) | 2016-10-01 |
| Magnetic Resonance Spectroscopy (MRS) in Midlife Depression (NCT02567110) | Emory University | 2016-07-01 |
| Study of a Vestibular Biomarker of Phase in Bipolar Disorder (NCT02827045) | Vest Brain,Centro de Estudios Neurovestibulares | 2016-07-01 |
| Dallas 2K: A Natural History Study of Depression (NCT02919280) | University of Texas Southwestern Medical Center | 2016-06-14 |
| Study of the Effectiveness of Vestibular Stimulation Treatment in the Depressive Phase of Bipolar Disorder (NCT02778256) | Vest Brain,Centro de Estudios Neurovestibulares | 2016-06-01 |
| Long Term Follow-up of Deep Brain Stimulation for Treatment-Resistant Depression (NCT03360942) | Dartmouth-Hitchcock Medical Center | 2016-04-18 |
| Combined Cytidine and Creatine-containing Drug in the Treatment of the Bipolar Depression (NCT02625779) | Ewha Womans University Mokdong Hospital | 2016-03-01 |
| Pharmacogenetic Implementation Trial in Veterans With Treatment Refractory Depression (NCT04469322) | San Diego Veterans Healthcare System | 2014-09-30 |
| Deep Brain Stimulation (DBS) for Treatment-Resistant Depression (TRD) (NCT01898429) | Paul Holtzheimer | 2013-07-01 |
| Safety, Tolerability, and Efficacy of Cariprazine in Participants With Bipolar Depression (NCT01396447) | Forest Laboratories | 2011-07-26 |
| An Investigation of Sleep Architecture in Ziprasidone-Treated Bipolar Depression (NCT00835107) | Queen's University | 2009-02-01 |
| Efficacy of Olanzapine Monotherapy for Treatment Bipolar Ⅰ Depression (NCT01303601) | China Medical University, China | 2009-01-01 |
| Functional and Neurochemical Brain Changes Bipolar Depression (NCT00608296) | University of Cincinnati | 2008-01-01 |
| Light-Therapy in the Treatment of the Acute Phase of the Bipolar Type II Depression (NCT00590265) | Douglas Mental Health University Institute | 2008-01-01 |
| Adjunctive Ziprasidone in the Treatment of Bipolar I Depression (NCT00483548) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2007-10-01 |
| Olanzapine Treatment of Patients With Bipolar I Disorder (NCT00510146) | Eli Lilly and Company | 2007-08-01 |
| Phase III/Seroquel SR Bipolar Depression Monotherapy - US (NCT00422214) | AstraZeneca | 2006-12-01 |
| Study Evaluating Bifeprunox in Bipolar Depression (NCT00245973) | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-06-01 |
| Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response (NCT00191399) | Eli Lilly and Company | 2004-05-01 |
| Depakote ER in Bipolar Depression (NCT00186186) | Stanford University | 2004-01-01 |
| Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar Depression (NCT00060489) | AstraZeneca | 2002-09-01 |